ConductScience.org, home

Paper16630353

Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis.

Altman R and 3 others. Thromb J, 2006. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis. Papers, record 16630353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16630353

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis.
PubMed
Journal
Thromb J
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2021-10-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Altman RRaul
2Scazziota ASAlejandra Silvia
3Herrera Mde LMaria de Lourdes
4Gonzalez CClaudio

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112231555Platelets and thrombin generation.Arterioscler Thromb Vasc Biol2002https://conductscience.org/library/papers/12231555PubMed
29819024A possible mechanism of action of activated factor VII independent of tissue factor.Blood Coagul Fibrinolysis1998https://conductscience.org/library/papers/9819024PubMed
37509511Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential.Thromb Haemost1993https://conductscience.org/library/papers/7509511PubMed
412871309Mechanism of action of recombinant factor VIIa.J Thromb Haemost2003https://conductscience.org/library/papers/12871309PubMed
514592825Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation.Blood2004https://conductscience.org/library/papers/14592825PubMed
611154121Effect of sodium arachidonate on thrombin generation through platelet activation--inhibitory effect of aspirin.Thromb Haemost2000https://conductscience.org/library/papers/11154121PubMed
79887164Atherosclerosis--an inflammatory disease.N Engl J Med1999https://conductscience.org/library/papers/9887164PubMed
815574198Blood coagulation and the risk of atherothrombosis: a complex relationship.Thromb J2004https://conductscience.org/library/papers/15574198PubMed
912105157
Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study.
Circulation2002https://conductscience.org/library/papers/12105157PubMed
1012904259Risk factors in coronary atherosclerosis athero-inflammation: the meeting point.Thromb J2003https://conductscience.org/library/papers/12904259PubMed
1116397140Tissue factor encryption.Arterioscler Thromb Vasc Biol2006https://conductscience.org/library/papers/16397140PubMed
1212010797Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo.Blood2002https://conductscience.org/library/papers/12010797PubMed
1314995996Rapid generation of thrombin by atheroma and platelets.J Thromb Haemost2004https://conductscience.org/library/papers/14995996PubMed
1416254201What does it take to make the perfect clot?Arterioscler Thromb Vasc Biol2006https://conductscience.org/library/papers/16254201PubMed
158578446Thrombin generation in plasma: its assessment via the endogenous thrombin potential.Thromb Haemost1995https://conductscience.org/library/papers/8578446PubMed
1616092924High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke.J Thromb Haemost2005https://conductscience.org/library/papers/16092924PubMed
1715117736Role of tissue factor in hemostasis, thrombosis, and vascular development.Arterioscler Thromb Vasc Biol2004https://conductscience.org/library/papers/15117736PubMed
189805008Lipid-protein interactions in blood coagulation.Biochim Biophys Acta1998https://conductscience.org/library/papers/9805008PubMed
1912855480Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs.Arterioscler Thromb Vasc Biol2003https://conductscience.org/library/papers/12855480PubMed
2015968399Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.Thromb Haemost2005https://conductscience.org/library/papers/15968399PubMed

See all 27 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
41525014Comparison of activated and 4-factor prothrombin complex concentrates for reversal of apixaban- and rivaroxaban-associated major bleeding.J Thromb Thrombolysis2026https://conductscience.org/library/papers/41525014PubMed
36975353Influence of a Physiologically Formed Blood Clot on Pre-Osteoblastic Cells Grown on a BMP-7-Coated Nanoporous Titanium Surface.Biomimetics (Basel)2023https://conductscience.org/library/papers/36975353PubMed
31905839Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets.J Clin Med2019https://conductscience.org/library/papers/31905839PubMed
27925685In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.J Thromb Haemost2017https://conductscience.org/library/papers/27925685PubMed
26667361The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension.J Thromb Thrombolysis2016https://conductscience.org/library/papers/26667361PubMed
22470429Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial.PLoS One2012https://conductscience.org/library/papers/22470429PubMed
20444280The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?Thromb J2010https://conductscience.org/library/papers/20444280PubMed
20194819Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.Am J Respir Crit Care Med2010https://conductscience.org/library/papers/20194819PubMed
17727726Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy.Thromb J2007https://conductscience.org/library/papers/17727726PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16630353

GET https://conductscience.org/api/papers/v1/16630353/references?page=2